Abstract Purpose To assess and compare the characteristics, therapy interventions, occurrence of uveitis and ocular complications in children with juvenile idiopathic arthritis (JIA) screened and examined for uveitis in Gothenburg, Sweden, over 20 years.
Pia Lundgren+7 more
wiley +1 more source
Clinical use of Infliximab in Crohn’s disease: the Edinburgh experience
Ian Arnott+3 more
openalex +1 more source
Progression and topographic subtypes of Terrien marginal degeneration
Abstract Purpose To report long‐term outcomes and to search for immunological and genetic risk factors in Terrien marginal degeneration (TMD). Methods Retrospective, in part prospective, hospital‐based longitudinal follow‐up study of 32 eyes of 16 Finnish patients from 2012 to 2023. Median follow‐up was 7.3 years (range, 0.3–15.2).
Minna Ruutila+8 more
wiley +1 more source
Characterization of the Regulatory Landscape in Crohn's Disease Reveals microRNA-Associated Alterations that Shape Anti-TNF Response. [PDF]
Cervera-Seco L+8 more
europepmc +1 more source
Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximab [PDF]
L P Robertson
openalex +1 more source
Long‐Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis
ABSTRACT Aim Presence of deep ulcerations (DU) at diagnosis seems to be predictive of a more severe phenotype in adult Crohn's disease (CD). The aim of our study was to investigate if the presence of DU at diagnosis was associated with a more severe disease course over time in children.
Monica S. Ronconi+8 more
wiley +1 more source
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor α [PDF]
Filip Van den Bosch+5 more
openalex +1 more source
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
In total 169 patients already exposed to a JAKi and who received a second JAKi were retrospectively studied across 28 GETAID centres, with 48% reaching steroids‐free clinical remission after induction. Adverse events led to treatment discontinuation in 5% of cases.
Mathilde Osty+56 more
wiley +1 more source
Dashboard-Guided Anti-TNF Induction: An Effective Strategy to Minimize Immunogenicity While Avoiding Immunomodulators-A Single-Center Cohort Study. [PDF]
Céspedes-Martínez E+8 more
europepmc +1 more source